vs
Church & Dwight(CHD)与景顺(IVZ)财务数据对比。点击上方公司名可切换其他公司
景顺的季度营收约是Church & Dwight的1.0倍($1.7B vs $1.6B),Church & Dwight净利率更高(8.7% vs -58.9%,领先67.6%),景顺同比增速更快(6.2% vs 3.9%),过去两年景顺的营收复合增速更高(7.1% vs 4.6%)
Church & Dwight是美国知名消费品企业,成立于1847年,总部位于新泽西州尤因。公司主营个人护理、家居用品及特色产品,旗下拥有Arm & Hammer、Trojan、OxiClean等知名品牌,2022年全年营收达54亿美元。
景顺是总部位于美国佐治亚州亚特兰大的独立投资管理企业,在全球20个国家设有分支机构,旗下运营景顺、Invesco Perpetual、PowerShares等品牌,普通股为标普500指数成分股,于纽约证券交易所挂牌交易。
CHD vs IVZ — 直观对比
营收规模更大
IVZ
是对方的1.0倍
$1.6B
营收增速更快
IVZ
高出2.3%
3.9%
净利率更高
CHD
高出67.6%
-58.9%
两年增速更快
IVZ
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.6B | $1.7B |
| 净利润 | $143.5M | $-995.9M |
| 毛利率 | 45.8% | — |
| 营业利润率 | 16.2% | -86.2% |
| 净利率 | 8.7% | -58.9% |
| 营收同比 | 3.9% | 6.2% |
| 净利润同比 | -24.2% | -575.8% |
| 每股收益(稀释后) | $0.60 | $-2.61 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CHD
IVZ
| Q4 25 | $1.6B | $1.7B | ||
| Q3 25 | $1.6B | $1.6B | ||
| Q2 25 | $1.5B | $1.5B | ||
| Q1 25 | $1.5B | $1.5B | ||
| Q4 24 | $1.6B | $1.6B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.5B | $1.5B | ||
| Q1 24 | $1.5B | $1.5B |
净利润
CHD
IVZ
| Q4 25 | $143.5M | $-995.9M | ||
| Q3 25 | $182.2M | $356.4M | ||
| Q2 25 | $191.0M | $197.4M | ||
| Q1 25 | $220.1M | $171.1M | ||
| Q4 24 | $189.2M | $209.3M | ||
| Q3 24 | $-75.1M | $55.0M | ||
| Q2 24 | $243.5M | $132.2M | ||
| Q1 24 | $227.7M | $141.5M |
毛利率
CHD
IVZ
| Q4 25 | 45.8% | — | ||
| Q3 25 | 45.1% | — | ||
| Q2 25 | 43.0% | — | ||
| Q1 25 | 45.0% | — | ||
| Q4 24 | 44.7% | — | ||
| Q3 24 | 45.2% | — | ||
| Q2 24 | 47.1% | — | ||
| Q1 24 | 45.7% | — |
营业利润率
CHD
IVZ
| Q4 25 | 16.2% | -86.2% | ||
| Q3 25 | 16.1% | 16.5% | ||
| Q2 25 | 17.4% | 14.1% | ||
| Q1 25 | 20.1% | 18.1% | ||
| Q4 24 | 16.2% | 19.6% | ||
| Q3 24 | -6.1% | 6.6% | ||
| Q2 24 | 22.3% | 13.9% | ||
| Q1 24 | 20.3% | 14.4% |
净利率
CHD
IVZ
| Q4 25 | 8.7% | -58.9% | ||
| Q3 25 | 11.5% | 21.7% | ||
| Q2 25 | 12.7% | 13.0% | ||
| Q1 25 | 15.0% | 11.2% | ||
| Q4 24 | 12.0% | 13.1% | ||
| Q3 24 | -5.0% | 3.6% | ||
| Q2 24 | 16.1% | 8.9% | ||
| Q1 24 | 15.1% | 9.6% |
每股收益(稀释后)
CHD
IVZ
| Q4 25 | $0.60 | $-2.61 | ||
| Q3 25 | $0.75 | $0.66 | ||
| Q2 25 | $0.78 | $-0.03 | ||
| Q1 25 | $0.89 | $0.38 | ||
| Q4 24 | $0.76 | $0.46 | ||
| Q3 24 | $-0.31 | $0.12 | ||
| Q2 24 | $0.99 | $0.29 | ||
| Q1 24 | $0.93 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $409.0M | $1.0B |
| 总债务越低越好 | $2.2B | $1.8B |
| 股东权益账面价值 | $4.0B | $12.2B |
| 总资产 | $8.9B | $27.1B |
| 负债/权益比越低杠杆越低 | 0.55× | 0.15× |
8季度趋势,按日历期对齐
现金及短期投资
CHD
IVZ
| Q4 25 | $409.0M | $1.0B | ||
| Q3 25 | $305.3M | $973.1M | ||
| Q2 25 | $923.2M | $922.7M | ||
| Q1 25 | $1.1B | $821.7M | ||
| Q4 24 | $964.1M | $986.5M | ||
| Q3 24 | $752.1M | $1.0B | ||
| Q2 24 | $491.7M | $878.5M | ||
| Q1 24 | $349.7M | $895.7M |
总债务
CHD
IVZ
| Q4 25 | $2.2B | $1.8B | ||
| Q3 25 | $2.2B | $1.6B | ||
| Q2 25 | $2.2B | $1.9B | ||
| Q1 25 | $2.2B | $964.8M | ||
| Q4 24 | $2.2B | $890.6M | ||
| Q3 24 | $2.2B | $890.3M | ||
| Q2 24 | $2.2B | $890.1M | ||
| Q1 24 | $2.2B | $1.3B |
股东权益
CHD
IVZ
| Q4 25 | $4.0B | $12.2B | ||
| Q3 25 | $4.2B | $14.0B | ||
| Q2 25 | $4.4B | $13.9B | ||
| Q1 25 | $4.6B | $14.7B | ||
| Q4 24 | $4.4B | $14.6B | ||
| Q3 24 | $4.2B | $14.8B | ||
| Q2 24 | $4.3B | $14.6B | ||
| Q1 24 | $4.1B | $14.6B |
总资产
CHD
IVZ
| Q4 25 | $8.9B | $27.1B | ||
| Q3 25 | $9.1B | $28.4B | ||
| Q2 25 | $8.8B | $28.5B | ||
| Q1 25 | $9.0B | $28.1B | ||
| Q4 24 | $8.9B | $27.0B | ||
| Q3 24 | $8.7B | $27.5B | ||
| Q2 24 | $8.8B | $27.2B | ||
| Q1 24 | $8.6B | $28.1B |
负债/权益比
CHD
IVZ
| Q4 25 | 0.55× | 0.15× | ||
| Q3 25 | 0.52× | 0.12× | ||
| Q2 25 | 0.50× | 0.14× | ||
| Q1 25 | 0.48× | 0.07× | ||
| Q4 24 | 0.51× | 0.06× | ||
| Q3 24 | 0.53× | 0.06× | ||
| Q2 24 | 0.51× | 0.06× | ||
| Q1 24 | 0.54× | 0.09× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $455.8M |
| 自由现金流经营现金流 - 资本支出 | — | $432.2M |
| 自由现金流率自由现金流/营收 | — | 25.5% |
| 资本支出强度资本支出/营收 | 3.4% | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $1.4B |
8季度趋势,按日历期对齐
经营现金流
CHD
IVZ
| Q4 25 | — | $455.8M | ||
| Q3 25 | — | $606.2M | ||
| Q2 25 | — | $547.9M | ||
| Q1 25 | — | $-84.6M | ||
| Q4 24 | $292.3M | $316.9M | ||
| Q3 24 | $364.0M | $438.4M | ||
| Q2 24 | $236.9M | $489.1M | ||
| Q1 24 | $263.0M | $-54.4M |
自由现金流
CHD
IVZ
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $586.4M | ||
| Q2 25 | — | $530.4M | ||
| Q1 25 | — | $-108.0M | ||
| Q4 24 | $237.7M | $309.9M | ||
| Q3 24 | $315.4M | $410.0M | ||
| Q2 24 | $206.6M | $462.4M | ||
| Q1 24 | $216.7M | $-75.4M |
自由现金流率
CHD
IVZ
| Q4 25 | — | 25.5% | ||
| Q3 25 | — | 35.7% | ||
| Q2 25 | — | 35.0% | ||
| Q1 25 | — | -7.1% | ||
| Q4 24 | 15.0% | 19.5% | ||
| Q3 24 | 20.9% | 27.1% | ||
| Q2 24 | 13.7% | 31.2% | ||
| Q1 24 | 14.4% | -5.1% |
资本支出强度
CHD
IVZ
| Q4 25 | 3.4% | 1.4% | ||
| Q3 25 | 1.8% | 1.2% | ||
| Q2 25 | 1.5% | 1.2% | ||
| Q1 25 | 1.1% | 1.5% | ||
| Q4 24 | 3.5% | 0.4% | ||
| Q3 24 | 3.2% | 1.9% | ||
| Q2 24 | 2.0% | 1.8% | ||
| Q1 24 | 3.1% | 1.4% |
现金转化率
CHD
IVZ
| Q4 25 | — | — | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 2.78× | ||
| Q1 25 | — | -0.49× | ||
| Q4 24 | 1.54× | 1.51× | ||
| Q3 24 | — | 7.97× | ||
| Q2 24 | 0.97× | 3.70× | ||
| Q1 24 | 1.16× | -0.38× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHD
| Household Products | $645.3M | 39% |
| Personal Care Products | $625.9M | 38% |
| Consumer International | $299.8M | 18% |
| Specialty Products Division | $73.2M | 4% |
IVZ
| Investment Advice | $1.2B | 73% |
| Distribution And Shareholder Service | $382.7M | 23% |
| Financial Service Other | $51.0M | 3% |
| Investment Performance | $28.9M | 2% |